Cargando…
Monoclonal antibody-based therapies for microbial diseases
The monoclonal antibody (mAb) revolution that currently provides many new options for the treatment of neoplastic and inflammatory diseases has largely bypassed the field of infectious diseases. Only one mAb is licensed for use against an infectious disease, although there are many in various stages...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810317/ https://www.ncbi.nlm.nih.gov/pubmed/20006139 http://dx.doi.org/10.1016/j.vaccine.2009.09.105 |